SCHEMBL1956589

SCHEMBL1956589

CCCCOC(=O)c1ccc2c(C3CCCCC3)c(-c3ccccc3OCC(=O)N(C)CCCCN(C)S(N)(=O)=O)n(C3CCCC3)c2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 1/20 0.36
MMP12 P39900 1/20 0.36
KCNH2 Q12809 7/20 0.33
CYP3A4 P08684 3/20 0.33
SCN5A Q14524 2/20 0.33
NR1I2 O75469 6/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
TSHR P16473 1/20 0.32
SLC6A2 P23975 1/20 0.32
SCN1A P35498 1/20 0.32
SLC6A3 Q01959 1/20 0.32
HIF1A Q16665 1/20 0.32
SCN2A Q99250 1/20 0.32
SCN3A Q9NY46 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1954944 0.90 PRKCA (0.45) PRKCAMMP12KCNH2CYP3A4SCN5A
SCHEMBL1981129 0.90 PRKCA (0.37) PRKCAMMP12KCNH2CYP3A4SCN5A
SCHEMBL1956164 0.83 SCN9A (0.41) PRKCAMMP12KCNH2CYP3A4SCN5A
SCHEMBL1954720 0.82 PRKCA (0.46) PRKCAMMP12CYP3A4NR1I2CYP2C9
SCHEMBL1954406 0.79 PRKCA (0.37) PRKCAMMP12KCNH2CYP3A4SCN5A
SCHEMBL1980588 0.78 SCN9A (0.36) PRKCAMMP12CYP3A4NR1I2CYP2C9
SCHEMBL1953999 0.77 PRKCA (0.45) PRKCAMMP12CYP3A4NR1I2CYP2C9
SCHEMBL1981016 0.73 SCN9A (0.36) PRKCAMMP12CYP3A4NR1I2CYP2C9
SCHEMBL1957388 0.73 PRKCA (0.40) PRKCAMMP12CYP3A4NR1I2CYP2C9
SCHEMBL12595728 0.73 PRKCA (0.34) PRKCAMMP12CYP3A4NR1I2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2331554-A1 MACROCYCLIC INDOLE DERIVATIVES USEFUL AS HEPATITIS C VIRUS INHIBITORS Tibotec Pharmaceuticals (IE) 2011-06-15 EP disclosed